About Shengjun Ren
Shengjun Ren is a chief executive officer and director at RenaBio Therapeutics.
Shengjun Ren first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Shengjun Ren in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shengjun Ren works with at each company, as listed on that company's latest Form D.
RenaBio Therapeutics, Inc. · Form D, Feb 26, 2025